Strattera 25 mg/1

Strattera 25 mg capsules contain atomoxetine hydrochloride, a non-stimulant medication used for ADHD management. This oral capsule is designed to help improve focus and reduce impulsivity.

Strattera 25 mg capsules are primarily used for the treatment of attention deficit hyperactivity disorder (ADHD). Atomoxetine hydrochloride works by affecting certain chemicals in the brain that contribute to hyperactivity and impulse control. This medication is often prescribed to help manage symptoms such as inattention, hyperactivity, and impulsiveness.

Common effects of Strattera 25 mg capsules may include decreased appetite, nausea, and stomach pain. Some users may also experience dizziness, fatigue, or mood changes. These effects can vary from person to person and may subside as the body adjusts to the medication.

Strattera 25 mg capsules should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should be stored at room temperature, away from moisture and heat. Always consult a healthcare provider before starting or stopping any medication.

Strattera 25 mg capsules may interact with certain medications, including MAO inhibitors, antidepressants, and other drugs that affect brain chemicals. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.